GENERAL ATLANTIC, L.P. Q4 2022 Filing
Filed February 14, 2023
Portfolio Value
$7.6T
Holdings
33
Report Date
Q4 2022
Filing Type
13F-HR
All Holdings (33 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ESMTUSDENGAGESMART | 97,209,436 | $1.7T | 22.64% | |
| 2 | OSH3EUROAK STREET HEALTH | 61,384,475 | $1.3T | 17.47% | |
| 3 | DLODLOCAL | 57,660,766 | $897.8B | 11.88% | |
| 4 | ALHCALIGNMENT HEALTHCARE | 60,993,323 | $717.3B | 9.49% | |
| 5 | 8DTSQUARESPACE | 22,361,073 | $495.7B | 6.56% | |
| 6 | XPXP, INC | 25,317,733 | $388.4B | 5.14% | |
| 7 | —HIRERIGHT | 32,109,898 | $380.8B | 5.04% | |
| 8 | ALKTALKAMI | 18,729,806 | $273.3B | 3.62% | |
| 9 | YOUCLEAR SECURE | 7,013,699 | $192.4B | 2.55% | |
| 10 | MBLYMOBILEYE | 4,761,905 | $167.0B | 2.21% | |
| 11 | EWCZEUROPEAN WAX CENTER | 13,110,492 | $163.2B | 2.16% | |
| 12 | KRTXKARUNA THERAPEUTICS | 716,158 | $140.7B | 1.86% | |
| 13 | DUOLDUOLINGO | 1,479,294 | $105.2B | 1.39% | |
| 14 | ETSYETSY | 737,648 | $88.4B | 1.17% | |
| 15 | RPRXROYALTY PHARMA | 1,500,000 | $59.3B | 0.78% | |
| 16 | HCMHUTCHMED | 4,000,000 | $59.1B | 0.78% | |
| 17 | DNAGINKGO BIOWORKS | 32,319,896 | $54.6B | 0.72% | |
| 18 | IMCRIMMUNOCORE | 950,000 | $54.2B | 0.72% | |
| 19 | —CINCOR PHARMA, INC | 4,209,470 | $51.7B | 0.68% | |
| 20 | FUTUFUTU | 1,111,544 | $45.2B | 0.60% | |
| 21 | IORSAMSARA | 2,446,379 | $30.4B | 0.40% | |
| 22 | CNTACENTESSA PHARMACEUTICALS | 9,681,818 | $30.0B | 0.40% | |
| 23 | PHVSPHARVARIS | 2,420,155 | $27.2B | 0.36% | |
| 24 | RSKDRISKIFIED | 5,324,998 | $24.6B | 0.33% | |
| 25 | BLNDBLEND LABS | 11,433,949 | $16.5B | 0.22% | |
| 26 | —ARCO PLATFORM LIMITED | 1,183,934 | $16.0B | 0.21% | |
| 27 | THRDTHIRD HARMONIC BIO | 2,958,762 | $12.7B | 0.17% | |
| 28 | —CHINA INDEX HOLDINGS | 10,122,769 | $9.4B | 0.12% | |
| 29 | —WISH | 18,288,478 | $8.9B | 0.12% | |
| 30 | OPENOPENDOOR | 6,321,519 | $7.3B | 0.10% | |
| 31 | BZFDBUZZFEED | 7,862,502 | $5.4B | 0.07% | |
| 32 | GROVGROVE COLLABORATIVE | 4,680,100 | $1.9B | 0.02% | |
| 33 | ADAGADAGENE | 264,000 | $349.8M | 0.00% |